Literature DB >> 26936306

Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study.

Petter Bjornstad1, David M Maahs2, Lindsey M Duca3, Laura Pyle4, Marian Rewers5, Richard J Johnson6, Janet K Snell-Bergeon5.   

Abstract

OBJECTIVE: Reduced insulin sensitivity (IS) is well documented in type 1 diabetes (T1D) and may contribute to vascular complications. We examined the association of estimated IS (eIS) with incident macro- and microvascular complications in adults with T1D in the prospective CACTI study.
METHODS: Participants (N=652) were 19-56 years old at baseline and re-examined 6.2±0.6years later. Urinary albumin excretion was measured, and categorized as microalbuminuria or greater. Diabetic retinopathy (DR) was based on self-reported history, proliferative DR (PDR) as history of laser eye therapy and coronary artery calcium (CAC) was measured using electron-beam CT. Progression of CAC was defined as a change in the square root transformed CAC volume score of ≥2.5. IS was estimated (eIS) by an equation derived from clamp studies. Predictors of each complication were examined using stepwise logistic regression and subjects with complications at baseline excluded. Age, T1D duration, sex, HbA1c, SBP, LDL-C, and eIS were considered for inclusion.
RESULTS: Greater eIS at baseline predicted lower odds of developing albuminuria (OR: 0.67, 95% CI 0.51-0.88), DR (OR 0.79, 0.64-0.97), PDR (OR: 0.76, 0.57-0.99) and CACp (OR: 0.71, 0.60-0.85) in multivariable models.
CONCLUSIONS: Greater eIS conferred protection from the development of vascular complications over 6-years in T1D.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Insulin resistance; Insulin sensitivity; Macrovascular complications; Microvascular complications; Type 1 diabetes

Mesh:

Year:  2016        PMID: 26936306      PMCID: PMC4834265          DOI: 10.1016/j.jdiacomp.2016.02.011

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  35 in total

Review 1.  Diabetic retinopathy.

Authors:  Donald S Fong; Lloyd Aiello; Thomas W Gardner; George L King; George Blankenship; Jerry D Cavallerano; Fredrick L Ferris; Ronald Klein
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.

Authors:  Peter Libby; David M Nathan; Kristin Abraham; John D Brunzell; Judith E Fradkin; Steven M Haffner; Willa Hsueh; Marian Rewers; B Tibor Roberts; Peter J Savage; Sonia Skarlatos; Momtaz Wassef; Cristina Rabadan-Diehl
Journal:  Circulation       Date:  2005-06-28       Impact factor: 29.690

3.  Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

Authors:  Lena M Thorn; Carol Forsblom; Johan Fagerudd; Merlin C Thomas; Kim Pettersson-Fernholm; Markku Saraheimo; Johan Wadén; Mats Rönnback; Milla Rosengård-Bärlund; Clas-Göran Af Björkesten; Marja-Riitta Taskinen; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

4.  Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population.

Authors:  David M Maahs; Gregory L Kinney; Paul Wadwa; Janet K Snell-Bergeon; Dana Dabelea; John Hokanson; James Ehrlich; Satish Garg; Robert H Eckel; Marian J Rewers
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

5.  Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women.

Authors:  J C Olson; D Edmundowicz; D J Becker; L H Kuller; T J Orchard
Journal:  Diabetes       Date:  2000-09       Impact factor: 9.461

6.  Reactive oxygen species have a causal role in multiple forms of insulin resistance.

Authors:  Nicholas Houstis; Evan D Rosen; Eric S Lander
Journal:  Nature       Date:  2006-04-13       Impact factor: 49.962

7.  Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.

Authors:  Trevor J Orchard; Yue-Fang Chang; Robert E Ferrell; Nancy Petro; Demetrius E Ellis
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

8.  Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control.

Authors:  Janet K Snell-Bergeon; John E Hokanson; Lisa Jensen; Todd MacKenzie; Gregory Kinney; Dana Dabelea; Robert H Eckel; James Ehrlich; Satish Garg; Marian Rewers
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

9.  Patient self-report of prior laser treatment reliably indicates presence of severe diabetic retinopathy.

Authors:  Michael A Grassi; D Anthony Mazzulla; Michael D Knudtson; Wendy W Huang; Kristine E Lee; Barbara E Klein; Dan L Nicolae; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2008-12-03       Impact factor: 5.258

10.  Regression of microalbuminuria in type 1 diabetes.

Authors:  Bruce A Perkins; Linda H Ficociello; Kristen H Silva; Dianne M Finkelstein; James H Warram; Andrzej S Krolewski
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

View more
  16 in total

1.  Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of MEtformin on CardiovasculaR Function in AdoLescents with Type 1 Diabetes (EMERALD) Studies.

Authors:  Petter Bjornstad; Melanie Cree-Green; Amy Baumgartner; Gregory Coe; Yesenia Garcia Reyes; Michal Schäfer; Laura Pyle; Judith G Regensteiner; Jane Eb Reusch; Kristen J Nadeau
Journal:  Pediatr Diabetes       Date:  2017-10-30       Impact factor: 4.866

2.  Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.

Authors:  Petter Bjornstad; Michal Schäfer; Uyen Truong; Melanie Cree-Green; Laura Pyle; Amy Baumgartner; Yesenia Garcia Reyes; Aristides Maniatis; Sunil Nayak; R Paul Wadwa; Lorna P Browne; Jane E B Reusch; Kristen J Nadeau
Journal:  Circulation       Date:  2018-12-18       Impact factor: 29.690

3.  Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Authors:  Petter Bjornstad; Julie A Lovshin; Yuliya Lytvyn; Genevieve Boulet; Leif E Lovblom; Omar N Alhuzaim; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-02-02       Impact factor: 19.112

4.  Leptin is associated with cardiopulmonary fitness independent of body-mass index and insulin sensitivity in adolescents with type 1 diabetes: a brief report from the EMERALD study.

Authors:  Petter Bjornstad; Melanie Cree-Green; Amy Baumgartner; Gregory Coe; Yesenia Garcia Reyes; Michal Schafer; Laura Pyle; Judith G Regensteiner; Jane E B Reusch; Kristen J Nadeau
Journal:  J Diabetes Complications       Date:  2017-03-14       Impact factor: 2.852

Review 5.  Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Authors:  Petter Bjornstad; Robert H Eckel
Journal:  Curr Diab Rep       Date:  2018-10-17       Impact factor: 4.810

Review 6.  The changing face of paediatric diabetes.

Authors:  Amy S Shah; Kristen J Nadeau
Journal:  Diabetologia       Date:  2020-01-02       Impact factor: 10.122

7.  Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes.

Authors:  Kalie L Tommerdahl; Petter Bjornstad; Jessica Kendrick; Melanie Cree-Green; Amy D Baumgartner; Laura Pyle; Jane E B Reusch; Kristen J Nadeau
Journal:  Diabetes Obes Metab       Date:  2020-12-23       Impact factor: 6.577

8.  Insulin-mediated muscle microvascular perfusion and its phenotypic predictors in humans.

Authors:  Kaitlin M Love; Linda A Jahn; Lee M Hartline; James T Patrie; Eugene J Barrett; Zhenqi Liu
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

Review 9.  Cardiovascular disease in diabetes, beyond glucose.

Authors:  Robert H Eckel; Karin E Bornfeldt; Ira J Goldberg
Journal:  Cell Metab       Date:  2021-07-21       Impact factor: 31.373

Review 10.  Lipid mediators of insulin signaling in diabetic kidney disease.

Authors:  Alla Mitrofanova; Marie Anne Sosa; Alessia Fornoni
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.